In diabetic kidney disease patients, a reduction in insulin levels, albuminuria, and the progression of renal failure were observed as a GLP-1R effect [56, 57]
LoCITT is dedicated to accelerating discoveries for the complex, multisystem condition which has affected the lives of more than 400 million people worldwide
Zolbetuximab is being proposed to treat patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive
It also enhances iron absorption , making it a critical co-factor for preventing iron deficiency anemia
All GLP-1 receptor agonists can cause constipation, but there do seem to be differences between them
It affects approximately 24% of the UK population, with a higher prevalence in women